Compliance. TODAY January Improving the Medicare audit process. an interview with Gerard (Jerry) Mulcahy. See page 16

Size: px
Start display at page:

Download "Compliance. TODAY January Improving the Medicare audit process. an interview with Gerard (Jerry) Mulcahy. See page 16"

Transcription

1 Compliance TODAY January 2017 a publication of the health care compliance association Improving the Medicare audit process an interview with Gerard (Jerry) Mulcahy Former Director, Medicare Parts C and D Oversight and Enforcement Group Centers for Medicare and Medicaid Services Baltimore, MD See page Cultivating young compliance professionals Natalie Bulger 26 Advocating for an annual compliance program review Ryan Burt and Mai Lee Yang 30 An in-depth interview with Robert K. DeConti, Part 2 Gabriel Imperato 38 HIPAA Privacy: Follow proper steps to avoid becoming a news headline Lina Pacelli This article, published in Compliance Today, appears here with permission from the Health Care Compliance Association. Call HCCA at with reprint requests.

2 by Joanna Malcolm, RN, CCM, BSN and Sherry E. Daugherty, RN, COC Medical necessity for cardiac procedures and devices Hospitals and physicians face increasing scrutiny over compliance with National Coverage Determinations (NCDs). A disconnect exists between NCDs and advances in evidence-based medicine. Missing, incomplete, or conflicting documentation creates denial risk for procedures. Physicians and hospitals must share the responsibility of medical necessity. Providers must develop effective education initiatives and compliance processes. Joanna Malcolm (jmalcolm@pyapc.com) is a Nurse Analyst & Consulting Manager and Sherry E. Daugherty (sdaugherty@pyapc.com) is a Nurse Analyst & Consulting Senior with PYA- Healthcare Management & Consulting Firm in Atlanta. bit.ly/in-sherrydaugherty The Department of Justice (DOJ) recently concluded a national probe of hospitals that allegedly billed for implanting cardiac defibrillators that were not medically necessary. As a result of the settlement, more than 500 hospitals agreed to reimburse the government nearly $500 million to resolve allegations they charged Medicare for procedures that did not comply with National Coverage Determination (NCD) 20.4 for implantable cardiac defibrillators (ICDs). 1 The DOJ investigation used data mining, claims denials, and whistleblower actions to isolate procedures that potentially violated the required waiting period for device placement under NCDs. As a result, most providers are now keenly aware of this technical guideline; however, the NCD also contains many other frequently overlooked indications, exclusions, and documentation requirements to support medical necessity. Additionally, the risk for non-compliance is not isolated to ICDs; other cardiac procedures and devices have coverage determinations that explicitly cover or exclude certain indications. The completion of the DOJ investigation does not mean the scrutiny has ended, or that the risk has receded. Providers both physicians and hospitals still face significant risk if they fail to adhere to NCD requirements. The recent DOJ probe demonstrates the need for focused education for physicians and staff, and implementation of policies and procedures to ensure compliance with the NCD. In doing so, providers can get to the heart of the matter: ensuring compliance with medical necessity standards. Malcolm Daugherty Background Implantable cardiac devices are used to treat cardiac arrhythmia, which is any disorder of the rate or rhythm of the heart (e.g., beating too quickly, too slowly, or with an irregular pattern). 2 ICDs are small, battery-powered devices implanted in the chest or abdomen during a minor surgical procedure, at a cost between $25,000 and $40, The cardiac devices used to treat arrhythmias include pacemakers, ICDs, and cardiac

3 resynchronization therapy devices (CRTs). Pacemakers help control abnormal heart rhythms by speeding up a slow rhythm, controlling a fast rhythm, or coordinating the chambers of the heart to beat in synchrony. ICDs can be single or dual chamber, or CRT devices that work in three chambers. An ICD monitors heart rhythms and will deliver a shock called defibrillation if it senses an abnormal rhythm. ICDs treat life-threatening arrhythmias that can lead to Figure 1: Medicare Coverage Determination Process Phase I (6 months) Preliminary Discussions External Technology Assessment and/or Medicare Coverage Advisory Committee Phase II (3 months) Final Decision Memorandum and Implementation Instructions (60 Days) Phase III (Possible) Final Decision Memorandum and Implementation Instructions Phase III (Possible) External Technology Assessment and/or Medicare Coverage Advisory Committee Benefit Category Staff Review Public Comments (30 Days) Department Appeals Board Staff Review National Coverage Request sudden cardiac death. Most ICDs can act as both pacemaker and defibrillator. Medicare coverage for these procedures and devices is limited to items and services that are reasonable and necessary for the diagnosis or treatment of an illness or injury, and also are within the scope of a Medicare benefit category. The not reasonable and necessary coverage exclusion is based on Title XVIII 1862(a) (1) of the Social Security Act. The Centers for Medicare & Medicaid Services (CMS) determines what is reasonable and necessary through the Medicare National Coverage Draft Decision Memorandum Posted OR Staff Review Draft Decision Memorandum Posted Process. The process is long and arduous, and frequently results in out-of-date coverage rules that conflict with the most recent technology and medical guidelines. As illustrated in Figure 1, the process takes a minimum of nine months. However, if the process results in reconsideration, which causes the process to begin anew, the process can take significantly longer. Assuming the process generates an NCD, CMS incorporates it into the National Coverage Determinations Manual (NCDs Manual). The NCDs

4 in this manual describe whether specific medical items, services, treatments, procedures, or technologies are paid for by Medicare and also may state that certain items are not covered. Three NCDs address device placement, and these NCDs contain 33 determinations. All three are located in Section 20 of the Medicare NCDs Manual. 4 To restrict coverage, the NCD must contain a statement that explicitly excludes the item or service from coverage. If the NCD fails to mention an indication or service (which includes providing coverage for specified indications or services, but remaining silent about its application in other circumstances), or fails to mention whether it is necessary in a particular circumstance, the local Medicare Administrative Contractor (MAC) has the discretion to make coverage decisions. 5 Local MACs also can develop coverage determinations to further clarify NCDs, or make their own Local Coverage Determinations (LCDs) for services or items that are not addressed in the NCDs Manual. Often, LCDs contain greater coding details, such as specific diagnosis codes that must be present for payment. The shared responsibility of medical necessity Physicians and hospitals share the responsibility of ensuring that items and services are reasonable and necessary for a diagnosis or treatment and comply with the standards and rules required by the government and private payers. 6 Physicians bear the responsibility of ordering the treatments they believe are the most appropriate for each patient s diagnosis and symptoms, based on their experience, knowledge of the patient, and current medical treatment guidelines, as well as payers complex standards of what is medically necessary. Hospitals also are prohibited from billing for services that are not medically necessary, but which are ordered and performed by physicians. This shared responsibility is based on the theory that the hospital knew, or should have known, that unnecessary procedures were performed. 7 Therefore, both the physician and hospital must know and apply the multitude of complex medical necessity determinations and payer guidelines for every service they provide. Physicians must balance the presentation of the patient in front of them with the most current clinical guidelines and medical necessity determinations, which frequently conflict with one another. Hospitals must balance the presentation of the patient, as described by the physician who orders the service, with the medical necessity determinations. The hospital also must document that the service was reasonable and necessary. The hospital is responsible for collecting the necessary documents from the physician s office, ensuring that these documents are included in the hospital s medical record, and that they comply with the coverage guidance. If the documentation is incomplete, conflicting, or missing, the hospital must then decide whether the service is reasonable and necessary based on the available documentation. As evidenced by the DOJ investigation, some hospitals have performed procedures that are inconsistent with Medicare s coverage and clinical guidelines. Although most cases investigated by the DOJ were based on violating technical timing requirements (e.g., inserting an ICD within 40 days of an acute myocardial infarction [MI] or within 3 months of revascularization [percutaneous coronary intervention or coronary artery bypass grafting]), other requirements found in the NCD and LCD could pose bigger risks for physicians and hospitals. Even if the majority of performed procedures are clinically justified, the issue of missing, incomplete, or conflicting documentation (between the physician s office

5 and hospital) puts the procedure at greatest risk for denial. Documenting to support medical necessity With the increased scrutiny surrounding the appropriateness of cardiac procedures, Figure 2: Avoidable Documentation Pitfalls for NCD 20.4 Implantable Automatic Defibrillators Documented Prior MI Left Ventricular Ejection Fraction (LVEF) Five of the eight covered indications for an ICD require the documentation of a prior MI. There are numerous ways to document a prior MI, but an explicit physician statement is the minimum requirement. Frequently, a physician will document the diagnosis of ischemic dilated cardiomyopathy as the indication for ICD placement. This diagnosis alone is insufficient since ischemia can result from an MI or it can result from chronically narrowed arteries when an MI has not occurred. Indications 3-8 require an LVEF of 35%. The LVEF frequently is either not documented at all, or documented as 35-40%. ICDs virtually are never placed without a measurement of LVEF by echocardiogram or radionuclide scanning; the study must be included in the medical record. ICDs are never indicated for LVEF of >35%. A statement of 35-40% will result in denial as not necessary. detailed clinical and hospital record documentation that supports the specific requirements of the NCDs and LCDs is the best defense against risk. Each coverage determination has indications that either are covered or not covered. All providers must be aware of and regularly document these requirements. In instances where current guidelines and appropriate-use recommendations may support treatment outside of the coverage requirements, physicians should include detailed documentation and reasoning for treatment decisions to alleviate regulatory pushback. Figures 2 and 3 show examples of the most frequently avoidable documentation issues for ICDs and pacemakers. Ventricular Tachycardia (VT) or Ventricular Fibrillation (VF) New York Heart Association (NYHA) class of heart failure Indications 1 and 2 allow ICD for the documented presence of VT or VF not associated with an MI or transient or reversible cause. Documentation must show that the arrhythmia is still present and poses a risk outside the immediate timing of an MI and that the revascularization procedure did not remove the risk. The record often fails to include documentation that the VT or VF was sustained (lasting longer than 30 seconds) and induced in an electrophysiology study that was performed more than 40 days following an MI, or more than 3 months following revascularization. Documentation should state when the MI or procedure was performed, when the arrhythmia was induced, and how long it lasted. Indications 5-8 require the documentation of NYHA class of heart failure between II-IV. Symptoms frequently are documented, but the actual class is not stated in the medical record as required. Clinical guidelines Regulations and coverage determinations can be slow in integrating new information about advances in medicine. There often is a disconnect between the coverage determinations and the most current advances in evidence-based medicine. For example, the American College of Cardiology (ACC) issues appropriate-use

6 criteria (AUC) documents that help define when it is or is not reasonable to perform a procedure. The ACC also issues clinical practice guidelines that review and consider the most current medical literature to advise physicians in clinical decision making by describing a broad range of generally acceptable approaches for the diagnosis, management, or prevention of certain diseases or conditions. Both of these types of documents represent the most current evidence-based treatments for cardiovascular care and Bradycardia routinely are used by physicians to guide their care. The most recent clinical guidelines and AUC for ICDs were issued in 2013; the most recent update to NCD 20.4 was in This disconnect creates an Symptomatic environment where physicians may, knowingly or unknowingly, practice outside of the payer guidelines, even though they also are using the most Atrial Fibrillation up-to-date patient care guidelines. In these instances, physician documentation should be detailed as to what criteria or guidelines are used to make treatment decisions. Additionally, documentation should specifically answer the following questions: 1. What are the patient s specific signs and symptoms? 2. What are the diagnostic tests that support the diagnosis? 3. What are the patient comorbidities that contribute to the clinical picture? 4. How can the treatment improve the patient s expected long-term mortality? Figure 3: Avoidable Documentation Pitfalls for NCD for Single and Dual Chamber Cardiac Pacemaker Both indications for coverage of pacemakers are for documented symptomatic bradycardia, which is defined as a heart rate less than 60 beats per minute. The physician frequently documents only bradycardia, without specifying the rate. Further, there may be documentation of an electrocardiogram that shows a rate higher than 60 beats per minute. This is easily avoidable through exhaustive documentation of the rate and determination of the particular study used to confirm the diagnosis. Without documented bradycardia of less than 60 beats per minute, a pacemaker will be deemed not medically necessary. Both indications require the presence of symptoms directly attributable to a heart rate of less than 60 beats per minute. These symptoms could include syncope, seizures, congestive heart failure, dizziness, or confusion. The documentation frequently fails to include the clinical symptoms that support the need for a pacemaker. Without documentation of the symptoms, such as a brief physician statement in the patient s history and physical notes, a pacemaker will not be deemed medically necessary. The diagnosis of Atrial Fibrillation (AF) is a non-covered indication for a pacemaker unless there also is symptomatic bradycardia or a plan to perform AV node ablation, which eliminates the heart s ability to pace itself. Many times a physician states AF as the indication for a pacemaker without any documentation of symptoms related to bradycardia. Many physicians are unaware of this exclusion, and need to include more detailed documentation to support pacemakers in patients with AF

7 5. How can the procedure potentially improve the patient s quality of life? 6. In what way will the limitations of the current coverage guidelines restrict the patient from the most appropriate treatment currently available? Compliance Today January 2017 Practical steps to mitigate the risk 56 As hospitals and physicians face greater scrutiny over their compliance with the NCDs, there will be a greater need to ensure that all healthcare providers understand the specifics of the coverage guidelines. Hospitals, as well as physician groups, need to develop an effective education initiative and compliance process for their providers and staff. The following checklist is a basic outline for building a compliance process that begins with the physician and ends with the hospital: DD Develop required training that addresses NCDs, specific requirements under the NCDs, and adequate compliance documentation for all physicians with hospital privileges. DD Develop a process and delegate responsibility for collecting, maintaining, and disseminating the NCDs within each specialty department. DD Develop and implement a specific checklist for ordering cardiac device procedures. The checklist should include producing the documentation to support medical necessity before the procedure can be scheduled. DD Develop and implement a specific checklist that must be completed within the hospital department prior to performing the procedure. DD Develop and implement a process for pre-billing monitoring and regular postpayment auditing for all cardiac device placements. DD Assign a physician champion who is knowledgeable of the NCD coverage requirements and who can serve as a resource when physicians order treatments outside of coverage guidelines. 1. Department of Justice, press release: Fifty-One Hospitals Pay United States More Than $23 Million to Resolve False Claims Act Allegations Related to Implantation of Cardiac Devices February 17, Available at 2. U.S National Library of Medicine: Pacemakers and Implantable Defibrillators Available at 3. Centers for Medicare & Medicaid Services: Inpatient Prospective Payment System Final Rule FY Available at 4 CMS: Medicare National Coverage Determinations Manual, revised December 10, Available at 5 Idem U.S.C. 1395y(a)(1)(a) 7. Department of Health and Human Services: OIG Compliance Program Guidelines for Hospitals. 63 Federal Register 8987, February 23, Available at False Claims Act Training Doesn t Have to Be Hard A Supplement to Your Deficit Reduction Act Compliance Training Program offers a clear, concise review of the False Claims Act and its impact on federal health care programs. BULK PRICING AVAILABLE FOR HCCA MEMBERS To order, visit or call

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012 IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the

More information

National Coverage Determination (NCD) for Cardiac Pacemakers (20.8)

National Coverage Determination (NCD) for Cardiac Pacemakers (20.8) Page 1 of 12 Centers for Medicare & Medicaid Services National Coverage Determination (NCD) for Cardiac Pacemakers (20.8) Tracking Information Publication Number 100-3 Manual Section Number 20.8 Manual

More information

Cardiac Pacemakers» 2013 HOSPITAL REIMBURSEMENT GUIDE

Cardiac Pacemakers» 2013 HOSPITAL REIMBURSEMENT GUIDE Cardiac Pacemakers» 2013 HOSPITAL REIMBURSEMENT GUIDE 2 Contents Page Introduction Medicare Coding and Payment Overview Hospital Inpatient Hospital Outpatient HCPCS Device Category C-Codes Coverage for

More information

Title: Automatic External Defibrillators Division: Medical Management Department: Utilization Management

Title: Automatic External Defibrillators Division: Medical Management Department: Utilization Management Retired Date: Page 1 of 7 1. POLICY DESCRIPTION: Automatic External Defibrillators 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management, Pharmacy,

More information

Re: National Coverage Analysis (NCA) for Implantable Cardioverter Defibrillators (CAG R4)

Re: National Coverage Analysis (NCA) for Implantable Cardioverter Defibrillators (CAG R4) December 20, 2017 Ms. Tamara Syrek-Jensen Director, Coverage & Analysis Group Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: National Coverage Analysis (NCA) for

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: April 21, 2017 Number: MG.MM.DM.10dC3v4 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

TEXAS - MAC - PART B - TRAILBLAZER RADIOLOGY TABLE OF CONTENTS

TEXAS - MAC - PART B - TRAILBLAZER RADIOLOGY TABLE OF CONTENTS RADIOLOGY TABLE OF CONTENTS CPT to LCD ID CodeMap Mappings... 3 - Automatic Implantable Cardiac Defibrillator (AICD) - 4C-58AB-R1 11 L26529- Cardiac Catheterization - 4C-50AB-R3... 20 L26534- Transthoracic

More information

Hospital and Physician Reimbursement Guide for ICD Implants

Hospital and Physician Reimbursement Guide for ICD Implants Hospital and Physician Reimbursement Guide for ICD Implants JULY 2014 CRDM Economics and Health Policy Hospital and Physician Reimbursement Guide for ICD Implants This guide has been developed to help

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review

More information

CATHETER ABLATION CODING & REIMBURSEMENT GUIDE. Updated September 2018

CATHETER ABLATION CODING & REIMBURSEMENT GUIDE. Updated September 2018 CATHETER ABLATION CODING & REIMBURSEMENT GUIDE Updated September 2018 TABLE OF CONTENTS Diagnosis Codes...3 ICD-10-CM Diagnosis Codes Coverage for Catheter Ablation Procedures....4 Medicare Other Payers

More information

The Federal Audit of Implantable Cardioverter-Defibrillator Implants

The Federal Audit of Implantable Cardioverter-Defibrillator Implants Journal of the American College of Cardiology Vol. 59, No. 14, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.12.026

More information

Newer pacemakers also can monitor your blood temperature, breathing, and other factors and adjust your heart rate to changes in your activity.

Newer pacemakers also can monitor your blood temperature, breathing, and other factors and adjust your heart rate to changes in your activity. Pacemakers & Defibrillators A pacemaker system consists of a battery, a computerized generator and wires with sensors called electrodes on one end. The battery powers the generator, and both are surrounded

More information

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees

More information

MEDICAL POLICY Cardioverter Defibrillators

MEDICAL POLICY Cardioverter Defibrillators POLICY........ PG-0224 EFFECTIVE......06/01/09 LAST REVIEW... 01/27/17 MEDICAL POLICY Cardioverter Defibrillators GUIDELINES This policy does not certify benefits or authorization of benefits, which is

More information

National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5

National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5 National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION CPT Codes: 93451, 93452, 93453, 93454, 93455, 93456, 93457, 93458, 93459, 93460, 93461 LCD ID Number:

More information

Clinical Policy: Microvolt T-Wave Alternans Testing Reference Number: CP.MP.212

Clinical Policy: Microvolt T-Wave Alternans Testing Reference Number: CP.MP.212 Clinical Policy: Reference Number: CP.MP.212 Effective Date: 03/05 Last Review Date: 09/17 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications

More information

Different indications for pacemaker implantation are the following:

Different indications for pacemaker implantation are the following: Patient Resources: ICD/Pacemaker Overview ICD/Pacemaker Overview What is a pacemaker? A pacemaker is a device that uses low energy electrical pulses to prompt the heart to beat whenever a pause in the

More information

Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc.

Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc. Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc. The Miracle of Living February 21, 2018 Matthew Ostrom MD,FACC,FHRS Division of

More information

Mission Statement for our Arrhythmia Care

Mission Statement for our Arrhythmia Care Mission Statement for our Arrhythmia Care We are dedicated to provide a compassionate and an outstanding care for patients with cardiac arrhythmias. We will be utilizing the cutting edge and the most advanced

More information

NHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006

NHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006 NHS National Institute for Health and Clinical Excellence Issue date: January 2006 Implantable cardioverter defibrillators (ICDs) for arrhythmias Understanding NICE guidance information for people with

More information

IMPLANTABLE CARDIODEFIBRILLATORS (ICDS)

IMPLANTABLE CARDIODEFIBRILLATORS (ICDS) IMPLANTABLE CARDIODEFIBRILLATORS (ICDS) Protocol: CAR024 Effective Date: June 1, 2018 Table of Contents Page DESCRIPTION... 1 COMMERCIAL & MEDICAID COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE...

More information

FREQUENTLY ASKED QUESTIONS MONITORING

FREQUENTLY ASKED QUESTIONS MONITORING Core Devices Pacemakers (PM) Implantable Cardioverter-Defibrillators (ICD) Cardiac Resynchronization Therapy (CRT) devices OptiVol Fluid Status Monitoring FREQUENTLY ASKED QUESTIONS MONITORING SEPTEMBER

More information

UnitedHealthcare Medicare Advantage Cardiology Prior Authorization Program

UnitedHealthcare Medicare Advantage Cardiology Prior Authorization Program Electrophysiology Implant Classification Table The table below contains the codes that apply to our UnitedHealthcare Medicare Advantage cardiology prior Description Includes Generator Placement Includes

More information

LCD L B-type Natriuretic Peptide (BNP) Assays

LCD L B-type Natriuretic Peptide (BNP) Assays LCD L30559 - B-type Natriuretic Peptide (BNP) Assays Contractor Information Contractor Name: Novitas Solutions, Inc. Contractor Number(s): 12501, 12502, 12101, 12102, 12201, 12202, 12301, 12302, 12401,

More information

Ambulatory Cardiac Monitors and Outpatient Telemetry Corporate Medical Policy

Ambulatory Cardiac Monitors and Outpatient Telemetry Corporate Medical Policy Ambulatory Cardiac Monitors and Outpatient Telemetry Corporate Medical Policy File Name: Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry File Code: UM.SPSVC.13 Origination: 10/2015 Last

More information

WATCHMAN. For questions regarding WATCHMAN reimbursement, please contact:

WATCHMAN. For questions regarding WATCHMAN reimbursement, please contact: WATCHMAN IMPORTANCE OF DOCUMENTATION & THE IMPACT ON MS- DRG ASSIGNMENT This guide stresses the importance of documentation in capturing the appropriate acuity level for patients considered WATCHMAN candidates.

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for

More information

Specialised Services Policy Position PP151

Specialised Services Policy Position PP151 Specialised Services Policy Position PP151 Complex Devices: Implantable Cardioverter Defibrillators and Cardiac Resynchronisation Therapy for arrhythmias and heart failure January 2019 Version 1.0 Document

More information

POLICIES AND PROCEDURE MANUAL

POLICIES AND PROCEDURE MANUAL POLICIES AND PROCEDURE MANUAL Policy: MP140 Section: Medical Benefit Policy Subject: Automatic Implantable Cardioverter-Defibrillator I. Policy: Automatic Implantable Cardioverter-Defibrillator II. Purpose/Objective:

More information

Sudden death from abnormal heart rhythm: Am I at risk?

Sudden death from abnormal heart rhythm: Am I at risk? DISCLAIMER: The views and opinions expressed in this presentation are those of the author. The slides in this presentation are prepared as talking points. It is possible that key substantive elements were

More information

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions The Clinical Revisions provide details of changes to InterQual Clinical Criteria. They do not provide information on changes made to CareEnhance

More information

HF10 THERAPY 2018 Ambulatory Surgery Center Reimbursement and Coding Reference Guide

HF10 THERAPY 2018 Ambulatory Surgery Center Reimbursement and Coding Reference Guide HF10 therapy, delivered by the Nevro Senza System, is the high-frequency spinal cord stimulation technology operated at 10,000 Hz designed to aid in the management of chronic intractable pain of the trunk

More information

2015 Procedural Payment Guide

2015 Procedural Payment Guide Contents Introduction Disclaimer (print page 2) Description of Payment Methods (print page 3) Procedural Payment Guide: Cardiac Rhythm Management and Electrophysiology Procedures (print page range: 4-17)

More information

b. To facilitate the management decision of a patient with an equivocal stress test.

b. To facilitate the management decision of a patient with an equivocal stress test. National Imaging Associates, Inc. Clinical guidelines EBCT HEART CT & HEART CT CONGENITAL CCTA CPT4 Codes: 75571 EBCT 75572, 75573 Heart CT & Heart CT Congenital 75574 - CCTA LCD ID Number: L33559 J K

More information

Common Codes for ICD-10

Common Codes for ICD-10 Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified

More information

SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS Protocol: CAR044 Effective Date: December 1, 2017 Table of Contents Page COMMERCIAL & MEDICAID COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE...

More information

Cardiac Rhythm Management Coder 2017

Cardiac Rhythm Management Coder 2017 Cardiac Rhythm Management Coder 2017 An easy-to-use tool for coding and reimbursement compliance Prepared and Published By: MedLearn Publishing, A Division of Panacea Healthcare Solutions, Inc. 287 East

More information

Fiscal Year (FY) 2019 Hospital Inpatient Proposed Rule Interventional Cardiology, Peripheral Interventions & Rhythm Management

Fiscal Year (FY) 2019 Hospital Inpatient Proposed Rule Interventional Cardiology, Peripheral Interventions & Rhythm Management Fiscal Year (FY) 2019 Hospital Inpatient Proposed Rule Interventional Cardiology, Peripheral Interventions & Rhythm Management On April 24, 2018, the Centers for Medicare & Medicaid Services (CMS) released

More information

PERFORMANCE MEASURE TECHNICAL SPECIFICATIONS. HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate

PERFORMANCE MEASURE TECHNICAL SPECIFICATIONS. HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate PERFORMANCE MEASURE TECHNICAL SPECIFICATIONS HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate Measure Title Description Measure Type Data Source Level of Analysis Numerator HRS-3:

More information

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L34834 Status: A-Approved

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L34834 Status: A-Approved LCD for Blood Glucose Monitoring in a Skilled Nursing Facility (SNF) (L34834) Contractor Name: Novitas Solutions, Inc. Contractor Number: 12502 Contractor Type: MAC B LCD ID Number: L34834 Status: A-Approved

More information

NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS

NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS OBJECTIVES Discuss history of ICDs Review the indications for ICD and CRT therapy Describe basic lead and device technology Discuss different therapies

More information

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function. National Imaging Associates, Inc. Clinical guidelines CARDIOVASCULAR NUCLEAR MEDICINE -MYOCARDIAL PERFUSION IMAGING -MUGA Original Date: October 2015 Page 1 of 9 FOR CMS (MEDICARE) MEMBERS ONLY CPT4 Codes:

More information

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function. National Imaging Associates, Inc. Clinical guidelines CARDIOVASCULAR NUCLEAR MEDICINE -MYOCARDIAL PERFUSION IMAGING -MUGA CPT4 Codes: Refer to pages 6-9 LCD ID Number: L33960 J 15 = KY, OH Responsible

More information

CMS Limitations Guide - Cardiovascular Services

CMS Limitations Guide - Cardiovascular Services CMS Limitations Guide - Cardiovascular Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations

More information

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Clinical Policy: Holter Monitors Reference Number: CP.MP.113 Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of

More information

PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists

PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists Craig A. McPherson, MD, FACC Associate Professor of Medicine Constantine Manthous, MD, FACP, FCCP Associate Clinical

More information

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia Need to Know: Implantable Devices Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia Disclosure Statement I have no relationships to disclose. Objectives Discuss the most

More information

Medical Necessity and Cardiovascular Procedures: What Providers and Payers Need to Know to Protect Their Patients and Bottom Lines

Medical Necessity and Cardiovascular Procedures: What Providers and Payers Need to Know to Protect Their Patients and Bottom Lines Medical Necessity and Cardiovascular Procedures: What Providers and Payers Need to Know to Protect Their Patients and Bottom Lines Thursday, March 14, 2013 Click here to begin the On-Demand recording of

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA88; Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block

More information

LCD Information Document Information LCD ID Number L30046

LCD Information Document Information LCD ID Number L30046 Local Coverage Determination (LCD): Pathology and Laboratory: B-type Natriuretic Peptide (BNP) Testing (L30046) LCD Information Document Information LCD ID Number L30046 LCD Title Pathology and Laboratory:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tseng ZH, Hayward RM, Clark NM, et al. Sudden death in patients with cardiac implantable electronic devices. JAMA Intern Med. Published online June 22, 2015. doi:10.1001/jamainternmed.2015.2641.

More information

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk

More information

Outpatient Cardiac Rehabilitation

Outpatient Cardiac Rehabilitation Last Review Date: May 12, 2017 Number: MG.MM.ME.26bC3v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

MICHIGAN CORONARY CTA PRIOR-AUTHORIZATION INFORMATIONAL GUIDE

MICHIGAN CORONARY CTA PRIOR-AUTHORIZATION INFORMATIONAL GUIDE Payer BlueCross BlueShield Michigan Priority Health Health Alliance Plan of Michigan Policy Name Clinical Appropriateness Guidelines: Computerized Tomographic Angiography Coronary evicore Cardiac Imaging

More information

Review guidance for patients on long-term amiodarone treatment

Review guidance for patients on long-term amiodarone treatment Review guidance for patients on long-term amiodarone treatment This review guidance document has been produced in response to: 1. Current supply shortages of branded and generic versions of 100mg and 200mg

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Cardiac Event Detection (L33952) MP-054-MC-KY Medical Management Provider Notice Date: 05/01/2018 Issue Date: 06/01/2018 Effective

More information

Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist

Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist Introduction. Basic Life Support (BLS). Advanced Cardiac Life Support (ACLS). Cardiovascular diseases (CVDs) are the number one cause of death

More information

Cardiac Rhythm Management Coder 2018

Cardiac Rhythm Management Coder 2018 Cardiac Rhythm Management Coder 2018 An easy-to-use tool for coding and reimbursement compliance Prepared and Published By: MedLearn Publishing, A Division of MedLearn Media, Inc. 445 Minnesota Street,

More information

Sepsis Denials. Presented by James Donaher, RHIA, CDIP, CCS, CCS-P

Sepsis Denials. Presented by James Donaher, RHIA, CDIP, CCS, CCS-P Sepsis Denials Presented by James Donaher, RHIA, CDIP, CCS, CCS-P Sepsis-1 2 From the first Sepsis Definition Conference in 1991 Defined sepsis as systemic response syndrome (SIRS) due to infection SIRS

More information

Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist

Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist LOTS!!! This presentation confines itself to the situation in the North West. The views expressed are my

More information

Electrophysiology. Jim Collins, CPC, CCC President, CardiologyCoder.Com, Inc. Two Types of Diagnostic EP Studies

Electrophysiology. Jim Collins, CPC, CCC President, CardiologyCoder.Com, Inc. Two Types of Diagnostic EP Studies Electrophysiology Jim Collins, CPC, CCC President, CardiologyCoder.Com, Inc. 1 Two Types of Diagnostic EP Studies 93619 Basic, Comprehensive Study RA Record His Record RV Record RA Pace RV Pace 93620 Comprehensive

More information

Summary of the Final 2013 Policy, Payment Changes For Hospital Outpatient Departments

Summary of the Final 2013 Policy, Payment Changes For Hospital Outpatient Departments Summary of the Final 2013 Policy, Payment Changes For Hospital Outpatient Departments A. Introduction On November 1, 2012, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that will

More information

2019 MITRACLIP CODING AND PAYMENT GUIDE

2019 MITRACLIP CODING AND PAYMENT GUIDE CLAIM 2019 MITRACLIP AND PAYMENT GUIDE MitraClip Transcatheter Mitral Valve Repair Hospital Rates: Effective October 1, 2018 Physician Rates: Effective January 1, 2019 References and Brief Summary 1 CLAIM

More information

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal

More information

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program: UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program: Electrophysiology Implant Code Classification Table The

More information

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden

More information

CRT Vs RV Pacing Benefits

CRT Vs RV Pacing Benefits CRT-P & CRT-D Indications According to Guidelines are Guidelines Fully Adopted? Salama H. Omar M.D. Prof. Critical Care Medicine, Cairo University CRT Vs RV Pacing Benefits 1 Benefit of Upgrade CTR-P &

More information

MEDICAL POLICY SUBJECT: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

MEDICAL POLICY SUBJECT: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MEDICAL POLICY SUBJECT: IMPLANTABLE CARDIOVERTER PAGE: 1 OF: 12 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle

Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle Thank you for taking the time to review the draft Cardiovascular Diseases and Disorders chapter. Please provide

More information

Cardiac Imaging in abnormal rhythm Role of MDCT

Cardiac Imaging in abnormal rhythm Role of MDCT Cardiac Imaging in abnormal rhythm Role of MDCT Cardiac Imaging in abnormal rhythm Role of MDCT Scope of the problem CT in Atrial Fibrillation CT and pacing Ventricular arrhythmia Other applications 1

More information

Cardiac resynchronisation therapy (biventricular pacing) for the treatment of heart failure

Cardiac resynchronisation therapy (biventricular pacing) for the treatment of heart failure NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal for the treatment of heart failure Final scope Appraisal objective To appraise the clinical and cost effectiveness of cardiac

More information

Fractional Flow Reserve (FFR) and instant wave-free Ratio (The ifr modality)

Fractional Flow Reserve (FFR) and instant wave-free Ratio (The ifr modality) 2017 Coding and Medicare payment guide Fractional Flow Reserve (FFR) and instant wave-free Ratio (The ifr modality) All coding, coverage, billing and payment information provided herein by Philips Volcano

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

Supplemental Material

Supplemental Material Supplemental Material 1 Table S1. Codes for Patient Selection Cohort Codes Primary PM CPT: 33206 or 33207 or 33208 (without 33225) ICD-9 proc: 37.81, 37.82, 37.83 Primary ICD Replacement PM Replacement

More information

1. CARDIOLOGY. These listings cannot be correctly interpreted without reference to the Preamble. Anes. $ Level

1. CARDIOLOGY. These listings cannot be correctly interpreted without reference to the Preamble. Anes. $ Level 1. CARDIOLOGY These listings cannot be correctly interpreted without reference to the Preamble. Anes. Referred Cases 33010 Consultation: To consist of examination, review of history, laboratory, X-ray

More information

MEDICAL POLICY Cardiac Event Monitors/ Cardiac Event Detection

MEDICAL POLICY Cardiac Event Monitors/ Cardiac Event Detection POLICY: PG0039 ORIGINAL EFFECTIVE: 10/01/11 LAST REVIEW: 12/12/17 MEDICAL POLICY Cardiac Event Monitors/ Cardiac Event Detection GUIDELINES This policy does not certify benefits or authorization of benefits,

More information

Coronary intravascular ultrasound (IVUS)

Coronary intravascular ultrasound (IVUS) 2017 Coding and Medicare payment guide Coronary intravascular ultrasound (IVUS) All coding, coverage, billing and payment information provided herein by Philips Volcano is gathered from third-party sources

More information

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by

More information

ESC Stockholm Arrhythmias & pacing

ESC Stockholm Arrhythmias & pacing ESC Stockholm 2010 Take Home Messages for Practitioners Arrhythmias & pacing Prof. Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece Disclosures Small teaching fees from

More information

OBJECTIVE. 1. Define defibrillation. 2. Describe Need and history of defibrillation. 3. Describe the principle and mechanism of defibrillation.

OBJECTIVE. 1. Define defibrillation. 2. Describe Need and history of defibrillation. 3. Describe the principle and mechanism of defibrillation. Defibrillators OBJECTIVE 1. Define defibrillation. 2. Describe Need and history of defibrillation. 3. Describe the principle and mechanism of defibrillation. 4. Types and classes of defibrillator 5. Describe

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart

More information

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy Chapter 9 Cardiac Arrhythmias Learning Objectives Define electrical therapy Explain why electrical therapy is preferred initial therapy over drug administration for cardiac arrest and some arrhythmias

More information

FY2015 Proposed Hospital Inpatient Rule Summary

FY2015 Proposed Hospital Inpatient Rule Summary FY2015 Proposed Hospital Inpatient Rule Summary Cardiac Rhythm Management (CRM) Electrophysiology (EP) Interventional Cardiology (IC) Peripheral Intervention (PI) On April 30, 2014, the Centers for Medicare

More information

Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Vascular Procedures 1

Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Vascular Procedures 1 GE Healthcare Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Vascular Procedures 1 January, 2013 www.gehealthcare.com/reimbursement This overview addresses coding, coverage,

More information

BIVENTRICULAR PACEMAKER (CARDIAC RESYNCHRONIZATION THERAPY) FOR THE TREATMENT OF HEART FAILURE

BIVENTRICULAR PACEMAKER (CARDIAC RESYNCHRONIZATION THERAPY) FOR THE TREATMENT OF HEART FAILURE FOR THE TREATMENT OF HEART FAILURE Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices

More information

DOWNLOAD OR READ : VALIDITY OF CARDIAC IMPLANTABLE ELECTRONIC DEVICES IN ASSESSING DAILY PHYSICAL ACTIVITY PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : VALIDITY OF CARDIAC IMPLANTABLE ELECTRONIC DEVICES IN ASSESSING DAILY PHYSICAL ACTIVITY PDF EBOOK EPUB MOBI DOWNLOAD OR READ : VALIDITY OF CARDIAC IMPLANTABLE ELECTRONIC DEVICES IN ASSESSING DAILY PHYSICAL ACTIVITY PDF EBOOK EPUB MOBI Page 1 Page 2 validity of cardiac implantable electronic devices in assessing

More information

About atrial fibrillation (AFib) Atrial Fibrillation (AFib) What is AFib? What s the danger? Who gets AFib?

About atrial fibrillation (AFib) Atrial Fibrillation (AFib) What is AFib? What s the danger? Who gets AFib? Understanding AFib Atrial Fibrillation (AFib) About AFib 3 How Your Heart Works 4 Types of AFib 5 Symptoms 5 Risk Factors 5 How is AFib Diagnosed? 6 Treatment 6 What to Ask Your Doctor 7 A normal heartbeat

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1. Patient Selection Codes, CIED Generator Procedures Code Type Code Description ICD9 Proc 00.51 Implantation of cardiac resynchronization defibrillator, total system [CRT-D]

More information

MEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP

MEDICAL POLICY POLICY TITLE T-WAVE ALTERNANS TESTING POLICY NUMBER MP Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY T-wave alternans is considered investigational as a technique

More information

Cardiovascular Emergencies. Chapter 12

Cardiovascular Emergencies. Chapter 12 Cardiovascular Emergencies Chapter 12 Cardiovascular Emergencies Cardiovascular disease (CVD) claimed 931,108 lives in the US during 2001. 2,551 per day Almost two people per minute! CVD accounts for 38.5%

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: signal_averaged_ecg 7/1992 10/2017 10/2018 10/2017 Description of Procedure or Service Signal-averaged electrocardiography

More information

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important step for

More information

Wearable Cardioverter-Defibrillators

Wearable Cardioverter-Defibrillators Wearable Cardioverter-Defibrillators Policy Number: 2.02.15 Last Review: 12/2017 Origination: 10/1988 Next Review: 12/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program: Notification and Prior Authorization Program: Electrophysiology Implant Classification Table The following chart contains the codes that require notification or prior authorization as part of UnitedHealthcare

More information

UNDERSTANDING ELECTROPHYSIOLOGY STUDIES

UNDERSTANDING ELECTROPHYSIOLOGY STUDIES UNDERSTANDING ELECTROPHYSIOLOGY STUDIES Testing and Treating Your Heart s Electrical System A Problem with Your Heart Rhythm The speed and pattern of a heartbeat is called the heart rhythm. The rhythm

More information

Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Procedures 1 Performed by Emergency Medicine Physicians

Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Procedures 1 Performed by Emergency Medicine Physicians GE Healthcare Reimbursement Information for Diagnostic Ultrasound and Ultrasound-guided Procedures 1 Performed by Emergency Medicine Physicians January, 2013 www.gehealthcare.com/reimbursement This overview

More information

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars on the 3 rd Wednesday of each month to address topics related to risk adjustment

More information

H F 1 0 T H E R A P Y R E I M B U R S E M E N T R E F E R E N C E G U I D E

H F 1 0 T H E R A P Y R E I M B U R S E M E N T R E F E R E N C E G U I D E HF10 therapy, delivered by the Nevro Senza System, is the high-frequency spinal cord stimulation technology designed to aid in the management of chronic intractable pain of the trunk/limbs without paresthesia.

More information